Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (341-350 of 489) with videos related to

Pageof 49
Sort By:
BJU International|April 3, 2009
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancerSanjay G Patel, Michael S Cookson, Daniel A Barocas, et al.
The Journal of Urology|January 10, 2004
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgeryMonica P Revelo, Michael S Cookson, Sam S Chang, et al.
The Journal of Urology|May 10, 2005
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomesDipen J Parekh, Michael S Cookson, William Chapman, et al.
The Journal of Urology|April 17, 2002
Percent of cancer in the biopsy set predicts pathological findings after prostatectomyDavid J Grossklaus, Christopher S Coffey, Scott B Shappell, et al.
Urologic Oncology|April 15, 2004
Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approachMatthew D Shuford, Elspeth M McDougall, Sam S Chang, et al.
The Journal of Urology|September 18, 2009
Urinary diversion trends at a high volume, single American tertiary care centerWilliam T Lowrance, Jon A Rumohr, Peter E Clark, et al.
Therapeutic Advances in Urology|October 3, 2014
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladderMichael S Cookson, Sam S Chang, Christine Lihou, et al.
The American Journal of Managed Care|November 29, 2017
The influence of provider characteristics and market forces on response to financial incentivesBrock O'Neil, Mark Tyson, Amy J Graves, et al.
The Journal of Urology|June 19, 2015
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United StatesDaniel A Barocas, Katherine Mallin, Amy J Graves, et al.
The Journal of Urology|March 17, 2009
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volumeJay H Fowke, Saundra S Motley, Joseph A Smith, et al.
Pageof 49

Showing results (341-350 of 489) with videos related to

Sort By:
Pageof 49
BJU International|April 3, 2009
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancerSanjay G Patel, Michael S Cookson, Daniel A Barocas, et al.
The Journal of Urology|January 10, 2004
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgeryMonica P Revelo, Michael S Cookson, Sam S Chang, et al.
The Journal of Urology|May 10, 2005
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomesDipen J Parekh, Michael S Cookson, William Chapman, et al.
The Journal of Urology|April 17, 2002
Percent of cancer in the biopsy set predicts pathological findings after prostatectomyDavid J Grossklaus, Christopher S Coffey, Scott B Shappell, et al.
Urologic Oncology|April 15, 2004
Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approachMatthew D Shuford, Elspeth M McDougall, Sam S Chang, et al.
The Journal of Urology|September 18, 2009
Urinary diversion trends at a high volume, single American tertiary care centerWilliam T Lowrance, Jon A Rumohr, Peter E Clark, et al.
Therapeutic Advances in Urology|October 3, 2014
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladderMichael S Cookson, Sam S Chang, Christine Lihou, et al.
The American Journal of Managed Care|November 29, 2017
The influence of provider characteristics and market forces on response to financial incentivesBrock O'Neil, Mark Tyson, Amy J Graves, et al.
The Journal of Urology|June 19, 2015
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United StatesDaniel A Barocas, Katherine Mallin, Amy J Graves, et al.
The Journal of Urology|March 17, 2009
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volumeJay H Fowke, Saundra S Motley, Joseph A Smith, et al.
Pageof 49